Name: Amphastar Pharmaceuticals, Inc. (AMPH) Financial Statements
Creator: FinSpry

Amphastar Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Amphastar Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	731.97	644.40	498.99	437.77	349.85	322.36	294.67
Cost of Revenue	358.11	293.27	250.13	24.60	13.90	9.40	187.68
Gross Profit	373.86	351.12	248.86	199.74	143.34	131.92	106.99
Operating Expenses
Research & Development	73.91	73.74	74.77	60.93	67.23	68.85	57.56
Selling, General & Administrative	94.52	80.39	66.59	68.92	65.16	63.11	58.04
Operating Expenses	168.44	154.13	141.36	129.85	132.39	131.96	115.61
Operating Income	205.42	196.99	107.50	69.89	10.95	-0.04	-8.62
Other Income/Expense
Interest Income	10.61	5.46	1.32	0.60	0.64	0.00	0.46
Interest Expense	30.34	27.16	1.85	-0.89	-0.37	0.00	0.24
Other Income/Expense	-16.23	5.91	242.24	-14.33	6.59	131.05	-1.52
Income
Income Before Tax	189.19	171.36	116.04	84.14	4.64	60.23	-9.93
Income Tax Expense	29.67	31.83	23.48	20.63	3.54	13.72	-3.27
Net Income	159.52	137.55	91.39	62.12	1.40	48.94	-5.74
Net Income - Continuous Operations	159.52	137.55	91.39	63.30	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	277.31	222.59	146.16	111.56	30.19	81.50	6.83
EBIT	189.23	169.42	117.89	323.05	5.01	60.35	-9.68
Depreciation & Amortization	57.21	25.20	23.80	22.20	20.50	17.10	0.00
Earnings Per Share
Basic EPS	3.00	3.00	2.00	1.00	-	1.00	-
Diluted EPS	3.00	3.00	2.00	1.00	-	1.00	-
Basic Shares Outstanding	48.43	48.27	48.55	47.78	47.04	46.98	46.40
Diluted Shares Outstanding	52.06	53.00	52.43	49.78	49.12	49.91	46.40